Molecular docking and dynamics guided approach to identify potential anti-inflammatory molecules as NRF2 activator to protect against drug-induced liver injury (DILI): a computational study

References

• Akbar, S., Das, S., Iqubal, A., & Ahmed, B. (2021). Synthesis, biological evaluation and molecular dynamics studies of oxadiazine derivatives as potential anti-hepatotoxic agents. Journal of Biomolecular Structure and Dynamics, 22(11), 1–18. https://doi.org/10.1080/07391102.2021.1938233
   Google Scholar
• Anderson, M. T., Staal, F. J., Gitler, C., Herzenberg, L. A., & Herzenberg, L. A. (1994). Separation of oxidant-initiated and redox-regulated steps in the NF-kappa B signal transduction pathway. Proceedings of the National Academy of Sciences, 91(24), 11527–11531. https://doi.org/10.1073/pnas.91.24.11527
   PubMed Web of Science ®Google Scholar
• Ayoup, M. S., Abu-Serie, M. M., Abdel-Hamid, H., & Teleb, M. (2021). Beyond direct Nrf2 activation; reinvestigating 1,2,4-oxadiazole scaffold as a master key unlocking the antioxidant cellular machinery for cancer therapy. European Journal of Medicinal Chemistry, 220, 113475. https://doi.org/10.1016/j.ejmech.2021.113475
   PubMed Web of Science ®Google Scholar
• Bjelakovic, G., Nikolova, D., Gluud, L. L., Simonetti, R. G., & Gluud, C. (2007). Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: Systematic review and meta-analysis. JAMA, 297(8), 842–857. https://doi.org/10.1001/jama.297.8.842
   PubMed Web of Science ®Google Scholar
• Collins, T. (1999). Acute and chronic inflammation. Robbins Pathologic Basis of Disease, 83–84.
   Google Scholar
• Fang, J., Yin, H., Yang, Z., Tan, M., Wang, F., Chen, K., Zuo, Z., Shu, G., Cui, H., Ouyang, P., Guo, H., Chen, Z., Huang, C., Geng, Y., & Liu, W. (2021). Vitamin E protects against cadmium-induced sub-chronic liver injury associated with the inhibition of oxidative stress and activation of Nrf2 pathway. Ecotoxicology and Environmental Safety, 208, 111610. https://doi.org/10.1016/j.ecoenv.2020.111610
   PubMed Web of Science ®Google Scholar
• Flohé, L., Brigelius-Flohé, R., Saliou, C., Traber, M. G., & Packer, L. (1997). Redox regulation of NF-kappa B activation. Free Radical Biology & Medicine, 22(6), 1115–1126.
   PubMed Web of Science ®Google Scholar
• Gagné, F. (2014). Oxidative stress. In François Gagné (Ed.), Biochemical ecotoxicology: Principles and methods (pp. 103–115). Elsevier. https://doi.org/10.1016/B978-0-12-411604-7.00006-4
   Google Scholar
• Garcia-Cortes, M., Robles-Diaz, M., Stephens, C., Ortega-Alonso, A., Lucena, M. I., & Andrade, R. J. (2020). Drug induced liver injury: An update. Archives of Toxicology, 94(10), 3381–3407.
   PubMed Web of Science ®Google Scholar
• Gorla, U. S., Gsn, K. R., Kulandaivelu, U., Alavala, R. R., Das, S., & Joseph, A. (2021). Bioflavonoids as potential target inhibitors in COVID-19: An in silico analysis. Journal of Research in Pharmacy, 25(6), 982–997. https://doi.org/10.29228/jrp.94
   Web of Science ®Google Scholar
• Haider, K., Ahmad, K., Najmi, A. K., Das, S., Joseph, A., & Shahar Yar, M. (2022). Design, synthesis, biological evaluation, and in silico studies of 2-aminobenzothiazole derivatives as potent PI3Kα inhibitors. Archiv Der Pharmazie, 355(10), 2200146. https://doi.org/10.1002/ardp.202200146
   Web of Science ®Google Scholar
• Halder, D., Das, S., Joseph, A., & Jeyaprakash, R. S. (2022). Molecular docking and dynamics approach to in silico drug repurposing for inflammatory bowels disease by targeting TNF alpha. Journal of Biomolecular Structure and Dynamics, 1–14. https://doi.org/10.1080/07391102.2022.2050948
   PubMedGoogle Scholar
• Halder, D., Das, S., Aiswarya, R., & Jeyaprakash, R. S. (2022). Molecular docking and dynamics based approach for the identification of kinase inhibitors targeting PI3Kα against non-small cell lung cancer: A computational study. RSC Advances, 12(33), 21452–21467. https://doi.org/10.1039/D2RA03451D
   PubMed Web of Science ®Google Scholar
• Halliwell, B. (2013). The antioxidant paradox: Less paradoxical now? British Journal of Clinical Pharmacology, 75(3), 637–644. https://doi.org/10.1111/j.1365-2125.2012.04272.x
   PubMed Web of Science ®Google Scholar
• Haque, T., Sasatomi, E., & Hayashi, P. H. (2016). Drug-induced liver injury: Pattern recognition and future directions. Gut and Liver, 10(1), 27–36. https://doi.org/10.5009/gnl15114
   PubMed Web of Science ®Google Scholar
• Jnoff, E., Albrecht, C., Barker, J. J., Barker, O., Beaumont, E., Bromidge, S., Brookfield, F., Brooks, M., Bubert, C., Ceska, T., Corden, V., Dawson, G., Duclos, S., Fryatt, T., Genicot, C., Jigorel, E., Kwong, J., Maghames, R., Mushi, I., … Courade, J.-P. (2014). Binding mode and structure-activity relationships around direct inhibitors of the Nrf2-Keap1 complex. ChemMedChem. 9(4), 699–705. https://doi.org/10.1002/cmdc.201300525
   PubMed Web of Science ®Google Scholar
• Knapp, B., Ospina, L., & Deane, C. M. (2018). Avoiding false positive conclusions in molecular simulation: The importance of replicas. Journal of Chemical Theory and Computation, 14(12), 6127–6138. https://doi.org/10.1021/acs.jctc.8b00391
   PubMed Web of Science ®Google Scholar
• Liu, W., Zeng, X., Liu, Y., Liu, J., Li, C., Chen, L., Chen, H., & Ouyang, D. (2021). The immunological mechanisms and immune-based biomarkers of drug-induced liver injury. Frontiers in Pharmacology, 12, 723940. https://doi.org/10.3389/fphar.2021.723940
   PubMed Web of Science ®Google Scholar
• Ntamo, Y., Ziqubu, K., Chellan, N., Nkambule, B. B., Nyambuya, T. M., Mazibuko-Mbeje, S. E., Gabuza, K. B., Marcheggiani, F., Tiano, L., & Dludla, P. V. (2021). Drug-induced liver injury: Clinical evidence of N-acetyl cysteine protective effects. Oxidative Medicine and Cellular Longevity, 2021(Dili), 3320325. https://doi.org/10.1155/2021/3320325
   PubMedGoogle Scholar
• Pizzino, G., Irrera, N., Cucinotta, M., Pallio, G., Mannino, F., Arcoraci, V., Squadrito, F., Altavilla, D., & Bitto, A. (2017). Oxidative stress: Harms and benefits for human health. Oxidative Medicine and Cellular Longevity, 2017, 8416763. https://doi.org/10.1155/2017/8416763
   PubMed Web of Science ®Google Scholar
• Raghunath, A., Nagarajan, R., Sundarraj, K., Palanisamy, K., & Perumal, E. (2019). Identification of compounds that inhibit the binding of Keap1a/Keap1b Kelch DGR domain with Nrf2 ETGE/DLG motifs in zebrafish. Basic & Clinical Pharmacology & Toxicology, 125(3), 259–270. https://doi.org/10.1111/bcpt.13222
   PubMed Web of Science ®Google Scholar
• Ramsay, R. R., Popovic‐Nikolic, M. R., Nikolic, K., Uliassi, E., & Bolognesi, M. L. (2018). A perspective on multi‐target drug discovery and design for complex diseases. Clinical and Translational Medicine, 7(1), 1-14. https://doi.org/10.1186/s40169-017-0181-2
   PubMedGoogle Scholar
• Raychaudhuri, R., Pandey, A., Das, S., Nannuri, S. H., Joseph, A., George, S. D., Vincent, A. P., & Mutalik, S. (2021). Nanoparticle impregnated self-supporting protein gel for enhanced reduction in oxidative stress: A molecular dynamics insight for lactoferrin-polyphenol interaction. International Journal of Biological Macromolecules, 189(August), 100–113. https://doi.org/10.1016/j.ijbiomac.2021.08.089
   PubMedGoogle Scholar
• Roos, K., Wu, C., Damm, W., Reboul, M., Stevenson, J. M., Lu, C., Dahlgren, M. K., Mondal, S., Chen, W., Wang, L., Abel, R., Friesner, R. A., & Harder, E. D. (2019). OPLS3e: Extending force field coverage for drug-like small molecules. Journal of Chemical Theory and Computation, 15(3), 1863–1874. https://doi.org/10.1021/acs.jctc.8b01026
   PubMed Web of Science ®Google Scholar
• Sesso, H. D., Buring, J. E., Christen, W. G., Kurth, T., Belanger, C., MacFadyen, J., Bubes, V., Manson, J. E., Glynn, R. J., & Gaziano, J. M. (2008). Vitamins E and C in the prevention of cardiovascular disease in men: The Physicians’ Health Study II randomized controlled trial. JAMA, 300(18), 2123–2133. https://doi.org/10.1001/jama.2008.600
   PubMed Web of Science ®Google Scholar
• Talevi, A. (2015). Multi-target pharmacology: Possibilities and limitations of the "skeleton key approach" from a medicinal chemist perspective. Frontiers in Pharmacology, 6(SEP), 205–207. https://doi.org/10.3389/fphar.2015.00205
   PubMedGoogle Scholar
• Tran, T., & Lee, W. M. (2013). DILI: New insights into diagnosis and management. Current Hepatitis Reports, 12(1), 53–58.
   PubMedGoogle Scholar
• Zhang, H., & Tsao, R. (2016). Dietary polyphenols, oxidative stress and antioxidant and anti-inflammatory effects. Current Opinion in Food Science, 8, 33–42. https://doi.org/10.1016/j.cofs.2016.02.002
   Web of Science ®Google Scholar
• Zhang, S. M., Cook, N. R., Albert, C. M., Gaziano, J. M., Buring, J. E., & Manson, J. E. (2008). Effect of combined folic acid, vitamin B6, and vitamin B12 on cancer risk in women: A randomized trial. JAMA, 300(17), 2012–2021. https://doi.org/10.1001/jama.2008.555
   PubMed Web of Science ®Google Scholar
• Zhou, Y., Wang, J., Zhang, D., Liu, J., Wu, Q., Chen, J., Tan, P., Xing, B., Han, Y., Zhang, P., Xiao, X., & Pei, J. (2021). Mechanism of drug-induced liver injury and hepatoprotective effects of natural drugs. Chinese Medicine (United Kingdom), 16(1), 1-32. https://doi.org/10.1186/s13020-021-00543-x
   Google Scholar